These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 15123733)

  • 1. Exposure of melanoma cells to dacarbazine results in enhanced tumor growth and metastasis in vivo.
    Lev DC; Onn A; Melinkova VO; Miller C; Stone V; Ruiz M; McGary EC; Ananthaswamy HN; Price JE; Bar-Eli M
    J Clin Oncol; 2004 Jun; 22(11):2092-100. PubMed ID: 15123733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dacarbazine causes transcriptional up-regulation of interleukin 8 and vascular endothelial growth factor in melanoma cells: a possible escape mechanism from chemotherapy.
    Lev DC; Ruiz M; Mills L; McGary EC; Price JE; Bar-Eli M
    Mol Cancer Ther; 2003 Aug; 2(8):753-63. PubMed ID: 12939465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemotherapy for melanoma: the resultant of conflicting vectors.
    Mitchell MS
    J Clin Oncol; 2004 Jun; 22(11):2043-5. PubMed ID: 15123732
    [No Abstract]   [Full Text] [Related]  

  • 4. Selumetinib plus dacarbazine versus placebo plus dacarbazine as first-line treatment for BRAF-mutant metastatic melanoma: a phase 2 double-blind randomised study.
    Robert C; Dummer R; Gutzmer R; Lorigan P; Kim KB; Nyakas M; Arance A; Liszkay G; Schadendorf D; Cantarini M; Spencer S; Middleton MR
    Lancet Oncol; 2013 Jul; 14(8):733-40. PubMed ID: 23735514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of interleukin-8 by human melanoma cells up-regulates MMP-2 activity and increases tumor growth and metastasis.
    Luca M; Huang S; Gershenwald JE; Singh RK; Reich R; Bar-Eli M
    Am J Pathol; 1997 Oct; 151(4):1105-13. PubMed ID: 9327744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parthenolide enhances dacarbazine activity against melanoma cells.
    Koprowska K; Hartman ML; Sztiller-Sikorska M; Czyz ME
    Anticancer Drugs; 2013 Sep; 24(8):835-45. PubMed ID: 23797801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metastatic lesions with and without interleukin-18-dependent genes in advanced-stage melanoma patients.
    Crende O; Sabatino M; Valcárcel M; Carrascal T; Riestra P; López-Guerrero JA; Nagore E; Mandruzzato S; Wang E; Marincola FM; Vidal-Vanaclocha F
    Am J Pathol; 2013 Jul; 183(1):69-82. PubMed ID: 23707237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dacarbazine in combination with bevacizumab for the treatment of unresectable/metastatic melanoma: a phase II study.
    Ferrucci PF; Minchella I; Mosconi M; Gandini S; Verrecchia F; Cocorocchio E; Passoni C; Pari C; Testori A; Coco P; Munzone E
    Melanoma Res; 2015 Jun; 25(3):239-45. PubMed ID: 25746039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination therapy with dacarbazine and statins improved the survival rate in mice with metastatic melanoma.
    Tsubaki M; Takeda T; Obata N; Kawashima K; Tabata M; Imano M; Satou T; Nishida S
    J Cell Physiol; 2019 Aug; 234(10):17975-17989. PubMed ID: 30834527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor immunotherapy in melanoma: strategies for overcoming mechanisms of resistance and escape.
    Zigler M; Villares GJ; Lev DC; Melnikova VO; Bar-Eli M
    Am J Clin Dermatol; 2008; 9(5):307-11. PubMed ID: 18717605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of a treatment strategy combining CCI-779 plus DTIC versus DTIC monotreatment in human melanoma in SCID mice.
    Thallinger C; Werzowa J; Poeppl W; Kovar FM; Pratscher B; Valent P; Quehenberger P; Joukhadar C
    J Invest Dermatol; 2007 Oct; 127(10):2411-7. PubMed ID: 17508024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination of dacarbazine and dimethylfumarate efficiently reduces melanoma lymph node metastasis.
    Valero T; Steele S; Neumüller K; Bracher A; Niederleithner H; Pehamberger H; Petzelbauer P; Loewe R
    J Invest Dermatol; 2010 Apr; 130(4):1087-94. PubMed ID: 19940857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of interleukin-8 in tumor growth and metastasis of human melanoma.
    Bar-Eli M
    Pathobiology; 1999; 67(1):12-8. PubMed ID: 9873223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting nodal in conjunction with dacarbazine induces synergistic anticancer effects in metastatic melanoma.
    Hardy KM; Strizzi L; Margaryan NV; Gupta K; Murphy GF; Scolyer RA; Hendrix MJ
    Mol Cancer Res; 2015 Apr; 13(4):670-80. PubMed ID: 25767211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined activity of temozolomide and the mTOR inhibitor temsirolimus in metastatic melanoma involves DKK1.
    Niessner H; Kosnopfel C; Sinnberg T; Beck D; Krieg K; Wanke I; Lasithiotakis K; Bonin M; Garbe C; Meier F
    Exp Dermatol; 2017 Jul; 26(7):598-606. PubMed ID: 28423208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual Encapsulated Dacarbazine and Zinc Phthalocyanine Polymeric Nanoparticle for Photodynamic Therapy of Melanoma.
    do Reis SRR; Helal-Neto E; da Silva de Barros AO; Pinto SR; Portilho FL; de Oliveira Siqueira LB; Alencar LMR; Dahoumane SA; Alexis F; Ricci-Junior E; Santos-Oliveira R
    Pharm Res; 2021 Feb; 38(2):335-346. PubMed ID: 33604784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypopigmentation in the sites of regressed melanoma metastases after successful dacarbazine therapy.
    Roider E; Schneider J; Flaig MJ; Ruzicka T; Kunte C; Berking C
    Int J Dermatol; 2012 Sep; 51(9):1142-4. PubMed ID: 21913905
    [No Abstract]   [Full Text] [Related]  

  • 18. Penetration of dacarbazine and its active metabolite 5-aminoimidazole-4-carboxamide into cutaneous metastases of human malignant melanoma.
    Joukhadar C; Klein N; Mader RM; Schrolnberger C; Rizovski B; Heere-Ress E; Pehamberger H; Strauchmann N; Jansen B; Müller M
    Cancer; 2001 Oct; 92(8):2190-6. PubMed ID: 11596037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The BRAF(V600E) inhibitor, PLX4032, increases type I collagen synthesis in melanoma cells.
    Jenkins MH; Croteau W; Mullins DW; Brinckerhoff CE
    Matrix Biol; 2015 Oct; 48():66-77. PubMed ID: 25989506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential response of primary and metastatic melanomas to neutrophils attracted by IL-8.
    Schaider H; Oka M; Bogenrieder T; Nesbit M; Satyamoorthy K; Berking C; Matsushima K; Herlyn M
    Int J Cancer; 2003 Jan; 103(3):335-43. PubMed ID: 12471616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.